Nutriband (NASDAQ:NTRBW) Trading 1.3% Higher – Here’s Why

Nutriband Inc. (NASDAQ:NTRBW) was up 1.3% during trading on Monday . The stock traded as high as $1.07 and last traded at $0.78. 3,314 shares were traded during mid-day trading, an increase of 47% from the average session volume of 2,257 shares. The stock had previously closed at $0.77.

Nutriband Price Performance

The stock’s 50-day moving average price is $1.15 and its 200 day moving average price is $1.34.

Hedge Funds Weigh In On Nutriband

An institutional investor recently bought a new stake in Nutriband stock. Empery Asset Management LP purchased a new position in shares of Nutriband Inc. (NASDAQ:NTRBW) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 40,218 shares of the company’s stock, valued at approximately $65,000. Nutriband comprises about 0.1% of Empery Asset Management LP’s holdings, making the stock its 20th largest holding.

Nutriband Company Profile

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.